Cure51 Alternatives & Competitors
12 companies similar to Cure51 — We want every patient to become a Cancer Survivor.
Companies similar to Cure51
Alterome Therapeutics, Inc
To Life!
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
BlossomHill Therapeutics, Inc.
Addressing urgent unmet medical needs through deeper science, true originality, and rich e...
Rival Readout
Competing with Cure51? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
DEM Biopharma, Inc.
Novel Target for Solid Tumors
RayzeBio
Targeted innovative radiopharmaceuticals for cancer
Prelude Therapeutics
Precision Oncology, Redefined.
Onchilles Pharma
Developing drug candidates that have the potential to be broadly effective against a wide...
OnCusp Therapeutics
We Bring Oncology Innovation to Life
Chordia Therapeutics Inc
We are passionate to deliver first in class cancer drugs to patients from Japan.
Promatix Biosciences Ltd
Using multi-omics to develop the next generation of cancer therapeutics
INOVOTION
Which molecule will stand out
About Cure51
Cure51, founded in 2021, is a TechBio startup revolutionizing cancer research through its pioneering global database of Cancer Survivors with the mission: “We want every patient to become a Cancer Survivor.” Founded in collaboration with leading oncology centers, Cure51 has identified over 1,500 survivors across 42 cou...
Creating precision oncology drugs, Establishing and maintaining global cancer networks, Data collection and analysis from cancer outlier patients, Developing multi-omics database and clinical libraries
Oncology Centers, Cancer Researchers, Pharmaceutical Companies, Healthcare Providers, Cancer Patients
TechBio, Cancer Survivor Database, Oncology Partnerships, Data Collection Platform, Multiomic Sequencing, Therapeutic Target Identification, Novel Drug Development, Aggressive Cancer Focus, Global Cancer Research, Scientific Community Validation, Central Lab Infrastructure, Cancer Research Collaboration, Bioinformatics, Personalized Medicine
B2B, Platform, DaaS
Licensing, Data Monetization, Project Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Cure51: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Cure51 on 25 Aug 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.